bushaid glp 1 reviews GLP-1 COMPANION JDD Buzz Series | GLP-1
Description
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
Ahadiat S-A, Hosseinian Z
Perry VH, Cunningham C, Holmes C
Drug Discovery 2007, 6, 109110
